Drug Shortage Report for 5% DEXTROSE INJECTION
| Report ID | 247474 |
| Drug Identification Number | 02403536 |
| Brand name | 5% DEXTROSE INJECTION |
| Common or Proper name | 5% DEXTROSE INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100mL |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2025-01-10 |
| Estimated end date | 2025-01-29 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-01-11 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Freeflex® 5% Dextrose Injection 100mL bag effective January 10, 2025, until January 29, 2025. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2025-01-10 | English | Compare |
| v2 | 2025-01-10 | French | Compare |
| v3 | 2025-01-11 | English | Compare |
Showing 1 to 3 of 3